This media is currently not available.
Quality of colonoscopy reports in IBD patients: preliminary audit according to ESGE 2022 standards
Poster Abstract

Aims

The quality of colonoscopy reports is essential for the follow-up and management of patients with inflammatory bowel disease (IBD), influencing diagnosis, disease activity assessment, dysplasia surveillance, and overall patient care. This study aimed to evaluate the compliance of colonoscopy reports from our center with ESGE 2022 standards and to identify areas for improvement, with the perspective of extending the audit over a two-year period.

Methods

A preliminary prospective analysis was conducted on 50 colonoscopy reports from patients followed for IBD, including 13 ulcerative colitis and 37 Crohn’s disease patients, of whom 7 had undergone previous surgery. ESGE indicators assessed included the precise indication for colonoscopy, quality of bowel preparation, Boston bowel preparation score, endoscopic activity score, performance of biopsies, terminal ileum intubation (TI), photodocumentation, and use of chromoendoscopy. Patients who had undergone surgery were excluded from items that were not applicable. Photodocumentation was not available in our center, and chromoendoscopy, although available, was not routinely used; these indicators were therefore considered non-assessable. For each ESGE indicator, the observed proportion was compared to the recommended threshold using a proportion z-test. This preliminary analysis will be extended over a two-year period to allow a more representative assessment of reporting practices and identify potential areas for quality improvement.

Results

Among the 50 reports analyzed, the precise indication for colonoscopy was clearly documented in 72% of cases (vs 95% ESGE, p = 0.0003). The quality of bowel preparation was reported in 100% of evaluable reports; however, the Boston score was reported in only 49% (vs 90%, p < 0.0001) and the endoscopic activity score in 16% (vs 90%, p < 0.0001).

Biopsies were performed in 84% of reports (vs 80%, p = 0.44), and terminal ileum intubation was documented in 66% of cases after excluding non-applicable items (vs 80%, p = 0.12). In post-surgical Crohn’s patients, the Rutgeerts score was documented in only 43% of cases.

Conclusions

This preliminary analysis shows that documentation in colonoscopy reports varies according to ESGE indicators. The precise indication for colonoscopy, Boston score, and endoscopic activity score were underreported, whereas biopsy performance and terminal ileum intubation were closer to ESGE standards. Extending the audit over a two-year period will provide a more comprehensive evaluation of compliance, help identify areas for improvement, and contribute to harmonizing colonoscopy reporting practices in our center.